The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
RSV Diagnostics-Global Market Insights and Sales Trends 2025
Synopsis
Respiratory Syncytial Virus (RSV) diagnostics refer to the various methods and tests used to detect and diagnose RSV infections. These diagnostics play a crucial role in identifying and managing RSV infections, especially in infants and young children who are more susceptible to severe respiratory illness caused by the virus.
The global RSV Diagnostics market size is expected to reach US$ 1331 million by 2029, growing at a CAGR of 8.7% from 2023 to 2029. The market is mainly driven by the significant applications of RSV Diagnostics in various end use industries. The expanding demands from the Hospitals & Clinics, Clinical Laboratories and Other, are propelling RSV Diagnostics market. Kits and Assays, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Instruments segment is estimated at % CAGR for the next seven-year period.
The RSV diagnostics market has been experiencing significant growth due to the high prevalence of RSV infections, especially among infants and young children. The market is driven by factors such as increasing awareness about RSV infections, advancements in diagnostic technologies, and the growing need for accurate and rapid diagnosis.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for RSV Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global RSV Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global RSV Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, RSV Diagnostics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of RSV Diagnostics covered in this report include BioMérieux, Abbott, Roche, BD, Thermo Fisher, Luminex, Danaher, Biocartis and Hologic, etc.
The global RSV Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
BioMérieux
Abbott
Roche
BD
Thermo Fisher
Luminex
Danaher
Biocartis
Hologic
Global RSV Diagnostics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global RSV Diagnostics market, Segment by Type:
Kits and Assays
Instruments
Other
Global RSV Diagnostics market, by Application
Hospitals & Clinics
Clinical Laboratories
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of RSV Diagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Respiratory Syncytial Virus (RSV) diagnostics refer to the various methods and tests used to detect and diagnose RSV infections. These diagnostics play a crucial role in identifying and managing RSV infections, especially in infants and young children who are more susceptible to severe respiratory illness caused by the virus.
The global RSV Diagnostics market size is expected to reach US$ 1331 million by 2029, growing at a CAGR of 8.7% from 2023 to 2029. The market is mainly driven by the significant applications of RSV Diagnostics in various end use industries. The expanding demands from the Hospitals & Clinics, Clinical Laboratories and Other, are propelling RSV Diagnostics market. Kits and Assays, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Instruments segment is estimated at % CAGR for the next seven-year period.
The RSV diagnostics market has been experiencing significant growth due to the high prevalence of RSV infections, especially among infants and young children. The market is driven by factors such as increasing awareness about RSV infections, advancements in diagnostic technologies, and the growing need for accurate and rapid diagnosis.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for RSV Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global RSV Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global RSV Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, RSV Diagnostics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of RSV Diagnostics covered in this report include BioMérieux, Abbott, Roche, BD, Thermo Fisher, Luminex, Danaher, Biocartis and Hologic, etc.
The global RSV Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
BioMérieux
Abbott
Roche
BD
Thermo Fisher
Luminex
Danaher
Biocartis
Hologic
Global RSV Diagnostics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global RSV Diagnostics market, Segment by Type:
Kits and Assays
Instruments
Other
Global RSV Diagnostics market, by Application
Hospitals & Clinics
Clinical Laboratories
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of RSV Diagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of RSV Diagnostics
1.1 RSV Diagnostics Market Overview
1.1.1 RSV Diagnostics Product Scope
1.1.2 RSV Diagnostics Market Status and Outlook
1.2 Global RSV Diagnostics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global RSV Diagnostics Market Size by Region (2018-2029)
1.4 Global RSV Diagnostics Historic Market Size by Region (2018-2023)
1.5 Global RSV Diagnostics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, RSV Diagnostics Market Size (2018-2029)
1.6.1 North America RSV Diagnostics Market Size (2018-2029)
1.6.2 Europe RSV Diagnostics Market Size (2018-2029)
1.6.3 Asia-Pacific RSV Diagnostics Market Size (2018-2029)
1.6.4 Latin America RSV Diagnostics Market Size (2018-2029)
1.6.5 Middle East & Africa RSV Diagnostics Market Size (2018-2029)
2 RSV Diagnostics Market by Type
2.1 Introduction
2.1.1 Kits and Assays
2.1.2 Instruments
2.1.3 Other
2.2 Global RSV Diagnostics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global RSV Diagnostics Historic Market Size by Type (2018-2023)
2.2.2 Global RSV Diagnostics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America RSV Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe RSV Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific RSV Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America RSV Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa RSV Diagnostics Revenue Breakdown by Type (2018-2029)
3 RSV Diagnostics Market Overview by Application
3.1 Introduction
3.1.1 Hospitals & Clinics
3.1.2 Clinical Laboratories
3.1.3 Other
3.2 Global RSV Diagnostics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global RSV Diagnostics Historic Market Size by Application (2018-2023)
3.2.2 Global RSV Diagnostics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America RSV Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe RSV Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific RSV Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America RSV Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa RSV Diagnostics Revenue Breakdown by Application (2018-2029)
4 RSV Diagnostics Competition Analysis by Players
4.1 Global RSV Diagnostics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in RSV Diagnostics as of 2022)
4.3 Date of Key Players Enter into RSV Diagnostics Market
4.4 Global Top Players RSV Diagnostics Headquarters and Area Served
4.5 Key Players RSV Diagnostics Product Solution and Service
4.6 Competitive Status
4.6.1 RSV Diagnostics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 BioMérieux
5.1.1 BioMérieux Profile
5.1.2 BioMérieux Main Business
5.1.3 BioMérieux RSV Diagnostics Products, Services and Solutions
5.1.4 BioMérieux RSV Diagnostics Revenue (US$ Million) & (2018-2023)
5.1.5 BioMérieux Recent Developments
5.2 Abbott
5.2.1 Abbott Profile
5.2.2 Abbott Main Business
5.2.3 Abbott RSV Diagnostics Products, Services and Solutions
5.2.4 Abbott RSV Diagnostics Revenue (US$ Million) & (2018-2023)
5.2.5 Abbott Recent Developments
5.3 Roche
5.3.1 Roche Profile
5.3.2 Roche Main Business
5.3.3 Roche RSV Diagnostics Products, Services and Solutions
5.3.4 Roche RSV Diagnostics Revenue (US$ Million) & (2018-2023)
5.3.5 BD Recent Developments
5.4 BD
5.4.1 BD Profile
5.4.2 BD Main Business
5.4.3 BD RSV Diagnostics Products, Services and Solutions
5.4.4 BD RSV Diagnostics Revenue (US$ Million) & (2018-2023)
5.4.5 BD Recent Developments
5.5 Thermo Fisher
5.5.1 Thermo Fisher Profile
5.5.2 Thermo Fisher Main Business
5.5.3 Thermo Fisher RSV Diagnostics Products, Services and Solutions
5.5.4 Thermo Fisher RSV Diagnostics Revenue (US$ Million) & (2018-2023)
5.5.5 Thermo Fisher Recent Developments
5.6 Luminex
5.6.1 Luminex Profile
5.6.2 Luminex Main Business
5.6.3 Luminex RSV Diagnostics Products, Services and Solutions
5.6.4 Luminex RSV Diagnostics Revenue (US$ Million) & (2018-2023)
5.6.5 Luminex Recent Developments
5.7 Danaher
5.7.1 Danaher Profile
5.7.2 Danaher Main Business
5.7.3 Danaher RSV Diagnostics Products, Services and Solutions
5.7.4 Danaher RSV Diagnostics Revenue (US$ Million) & (2018-2023)
5.7.5 Danaher Recent Developments
5.8 Biocartis
5.8.1 Biocartis Profile
5.8.2 Biocartis Main Business
5.8.3 Biocartis RSV Diagnostics Products, Services and Solutions
5.8.4 Biocartis RSV Diagnostics Revenue (US$ Million) & (2018-2023)
5.8.5 Biocartis Recent Developments
5.9 Hologic
5.9.1 Hologic Profile
5.9.2 Hologic Main Business
5.9.3 Hologic RSV Diagnostics Products, Services and Solutions
5.9.4 Hologic RSV Diagnostics Revenue (US$ Million) & (2018-2023)
5.9.5 Hologic Recent Developments
6 North America
6.1 North America RSV Diagnostics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe RSV Diagnostics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific RSV Diagnostics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America RSV Diagnostics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa RSV Diagnostics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 RSV Diagnostics Market Dynamics
11.1 RSV Diagnostics Industry Trends
11.2 RSV Diagnostics Market Drivers
11.3 RSV Diagnostics Market Challenges
11.4 RSV Diagnostics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
